Anuh Pharma Limited (NSE:ANUHPHR)

Anuh Pharma Statistics

Total Valuation

Anuh Pharma has a market cap or net worth of INR 7.63 billion. The enterprise value is 7.10 billion.

Market Cap	7.63B
Enterprise Value	7.10B

Important Dates

The last earnings date was Wednesday, May 20, 2026.

Earnings Date	May 20, 2026
Ex-Dividend Date	Aug 14, 2025

Share Statistics

Current Share Class	100.22M
Shares Outstanding	n/a
Shares Change (YoY)	-0.11%
Shares Change (QoQ)	-0.54%
Owned by Insiders (%)	72.90%
Owned by Institutions (%)	0.00%
Float	26.86M

Valuation Ratios

The trailing PE ratio is 18.58.

PE Ratio	18.58
Forward PE	n/a
PS Ratio	0.98
PB Ratio	2.17
P/TBV Ratio	2.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.74, with an EV/FCF ratio of -65.83.

EV / Earnings	17.29
EV / Sales	0.91
EV / EBITDA	10.74
EV / EBIT	12.98
EV / FCF	-65.83

Financial Position

The company has a current ratio of 2.22, with a Debt / Equity ratio of 0.00.

Current Ratio	2.22
Quick Ratio	1.44
Debt / Equity	0.00
Debt / EBITDA	0.00
Debt / FCF	-0.01
Interest Coverage	115.80

Financial Efficiency

Return on equity (ROE) is 12.10% and return on invested capital (ROIC) is 13.51%.

Return on Equity (ROE)	12.10%
Return on Assets (ROA)	6.43%
Return on Invested Capital (ROIC)	13.51%
Return on Capital Employed (ROCE)	15.43%
Weighted Average Cost of Capital (WACC)	7.03%
Revenue Per Employee	26.31M
Profits Per Employee	1.39M
Employee Count	295
Asset Turnover	1.46
Inventory Turnover	5.40

Taxes

In the past 12 months, Anuh Pharma has paid 131.75 million in taxes.

Income Tax	131.75M
Effective Tax Rate	24.30%

Stock Price Statistics

The stock price has decreased by -27.66% in the last 52 weeks. The beta is 0.50, so Anuh Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	-27.66%
50-Day Moving Average	78.14
200-Day Moving Average	81.08
Relative Strength Index (RSI)	40.00
Average Volume (20 Days)	61,005

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Anuh Pharma had revenue of INR 7.76 billion and earned 410.46 million in profits. Earnings per share was 4.10.

Revenue	7.76B
Gross Profit	1.76B
Operating Income	546.94M
Pretax Income	542.21M
Net Income	410.46M
EBITDA	660.76M
EBIT	546.94M
Earnings Per Share (EPS)	4.10

Balance Sheet

The company has 531.61 million in cash and 583,000 in debt, with a net cash position of 531.03 million.

Cash & Cash Equivalents	531.61M
Total Debt	583,000
Net Cash	531.03M
Net Cash Per Share	n/a
Equity (Book Value)	3.52B
Book Value Per Share	35.28
Working Capital	2.48B

Cash Flow

In the last 12 months, operating cash flow was -30.12 million and capital expenditures -77.70 million, giving a free cash flow of -107.82 million.

Operating Cash Flow	-30.12M
Capital Expenditures	-77.70M
Depreciation & Amortization	113.82M
Net Borrowing	-108.52M
Free Cash Flow	-107.82M
FCF Per Share	n/a

Margins

Gross margin is 22.73%, with operating and profit margins of 7.05% and 5.29%.

Gross Margin	22.73%
Operating Margin	7.05%
Pretax Margin	6.99%
Profit Margin	5.29%
EBITDA Margin	8.51%
EBIT Margin	7.05%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 1.96%.

Dividend Per Share	1.50
Dividend Yield	1.96%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	36.47%
Buyback Yield	0.11%
Shareholder Yield	2.07%
Earnings Yield	5.38%
FCF Yield	-1.41%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 15, 2025. It was a forward split with a ratio of 2.

Last Split Date	Jul 15, 2025
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	4